Safety and efficacy of the ACE-inhibitor ramipril in Alport syndrome: The double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport trial in pediatric patients.
Safety and efficacy of the ACE-inhibitor ramipril in Alport syndrome: The double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport trial in pediatric patients.
Gross O, Friede T, Hilgers R, Görlitz A, Gavenis K, Ahmed R, Dürr U (2012) ISRN Pediatrics. doi:10.5402/2012/436046.
